Correlation of vascular enhancement on MRI and clinical manifestations in patients with GCA
Rheumatology Advances in Practice · 15.06.2026 · 10 (3)
DOI: 10.1093/rap/rkag060 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rheumatology Advances in Practice, online erschienen am 03.07.2026. Verfasst von Nitin S Rai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, McMaster University, Hamilton, ON, Canada. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
GCA has diverse cranial manifestations, and cranial vessel MRI (cvMRI) can assess multiple arteries simultaneously. We aimed to determine whether vessel-specific enhancement on cvMRI correlates with clinical manifestations and diagnosis in GCA.
Methods
We conducted a retrospective cohort study of patients who underwent cvMRI for suspected GCA at a single academic centre. We assessed associations between vessel wall enhancement on cvMRI and anatomically expected GCA symptoms. We used univariate and multivariable logistic regression adjusting for age, sex and glucocorticoid exposure to assess the relationship between vessel abnormalities and a diagnosis of GCA.
Results
Among 439 patients, 153 (34.9%) were diagnosed with GCA. Median time (quartile 1 [Q1]–quartile 3 [Q3]) from glucocorticoid initiation to cvMRI was 11.5 days (Q1–Q3: 5.8–207.2). Maxillary and ophthalmic artery involvement were specific but insensitive for jaw claudication and vision loss, respectively (specificity 87.1%, 95% CI, 80.3–93.9 and 72.6%, 95% CI, 61.5–83.7; sensitivity 40.0%, 95% CI, 26.5–51.4 and 43.3%, 95% CI, 33.1–53.6, respectively). Headache showed no association with specific vessels. Any arterial enhancement was associated with GCA in univariate analysis, but only temporal artery involvement was predictive in multivariable analysis (odds ratio [OR] 5.20, 95% CI, 1.65–16.88), particularly when bilateral (OR 9.82, 95% CI, 2.82–38.32).
Conclusion
Temporal artery enhancement remains the strongest imaging correlate for a diagnosis of GCA. Vessel-specific enhancement on cvMRI correlates with vision loss and jaw claudication but not headache. cvMRI may aid diagnosis in diagnostically uncertain cases, even after glucocorticoid initiation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, McMaster University, Hamilton, ON, Canada.
- Department of Health Research Methods, Evidence, and Impact (HEI), McMaster University, Hamilton, ON, Canada.
- Department of Anesthesia, McMaster University, Hamilton, ON, Canada.
- Department of Pediatrics, McMaster University, Hamilton, ON, Canada.
- Research Methodology Centre, The Research Institute of St Joe's, St. Joseph's Healthcare, Hamilton, ON, Canada.
- Centre for Development of Best Practices in Health (CDBPH), Yaoundé Central Hospital, Yaoundé, Cameroon.
ORCID-Profile: Nitin S Rai, Rennie L Rhee, Ryan Rebello, Mats Junek
Zitieren
APA
Rai, N. S., Khosavirad, A., Mbuagbaw, L., Rhee, R. L., Rebello, R., Khalidi, N., & Junek, M. (2026). Correlation of vascular enhancement on MRI and clinical manifestations in patients with GCA. Rheumatology Advances in Practice, 10(3). https://doi.org/10.1093/rap/rkag060
Vancouver
Rai NS, Khosavirad A, Mbuagbaw L, Rhee RL, Rebello R, Khalidi N, et al. Correlation of vascular enhancement on MRI and clinical manifestations in patients with GCA. Rheumatology Advances in Practice. 2026;10(3). doi:10.1093/rap/rkag060
BibTeX
@article{Rai2026,
author = {Rai, Nitin S and Khosavirad, Azin and Mbuagbaw, Lawrence and Rhee, Rennie L and Rebello, Ryan and Khalidi, Nader and Junek, Mats},
title = {Correlation of vascular enhancement on MRI and clinical manifestations in patients with GCA},
journal = {Rheumatology Advances in Practice},
year = {2026},
volume = {10},
number = {3},
doi = {10.1093/rap/rkag060}
}
EUVIMED